Leaders of An Giang Province on Tuesday had a working session with representatives from the industrial park (IP) investment promotion association of the Republic of Korea on developing smart IPs in the locality.
Chairman of the An Giang People’s Committee Nguyen Thanh Binh (right) hands over an investment certificate for a $900m smart IP project to the representative of the Korean Smart IP.
The two sides will cooperate in building smart IPs to serve garment and textile, and metallurgy industries.
At the session, Chairman of the provincial People’s Committee Nguyen Thanh Binh handed over an investment plan certificate for a smart IP project worth nearly US$900 million to Oh Se-young – a representative of the Korean Smart IP.
Oh said that An Giang has favourable conditions for developing smart IPs, especially its human and land resources, adding that the Korean industrial park investment promotion association has called on many Korean firms to invest in the province.
The RoK’s smart IPs will use advanced and modern technologies, meeting international standards and Viet Nam’s regulations on environmental protection, he stressed.
Oh affirmed that with their experience and strengths in techniques and high-quality human resources, Korean enterprises are completely confident to become important and long-term partners of An Giang in its plan to promote textile & garment and light metallurgy sectors.
He hoped the provincial authorities would support Korean businesses in issues related to land and legal regulations, thus facilitating their investment in the province.
Binh said An Giang always creates the most favourable conditions for investors operating in the province.
The chairman called on more Korean enterprises to invest in An Giang in the future. — VNS
A series of seminars and business-to-business matching events were held in Seoul and Busan port cities, the Republic of Korea (RoK) during November, within the framework of the Techfest Vietnam 2019.
JW Pharmaceutical Corporation acquired Euvipharm, becoming the first Korean company to take over a Vietnamese pharmaceutical company and operate it directly.